Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$2.39 - $4.93 $80,292 - $165,623
-33,595 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$3.45 - $8.77 $6,858 - $17,434
1,988 Added 6.29%
33,595 $153,000
Q4 2021

Feb 07, 2022

BUY
$8.01 - $12.84 $94,982 - $152,256
11,858 Added 60.04%
31,607 $277,000
Q3 2021

Nov 04, 2021

BUY
$11.94 - $16.09 $6,423 - $8,656
538 Added 2.8%
19,749 $249,000
Q2 2021

Aug 06, 2021

BUY
$14.36 - $20.93 $34,937 - $50,922
2,433 Added 14.5%
19,211 $297,000
Q1 2021

May 06, 2021

BUY
$18.19 - $33.25 $96,625 - $176,624
5,312 Added 46.33%
16,778 $339,000
Q4 2020

Feb 09, 2021

BUY
$15.87 - $31.64 $41,753 - $83,244
2,631 Added 29.78%
11,466 $310,000
Q3 2020

Nov 10, 2020

SELL
$15.7 - $20.84 $3,187 - $4,230
-203 Reduced 2.25%
8,835 $163,000
Q2 2020

Aug 06, 2020

BUY
$8.21 - $21.02 $74,201 - $189,978
9,038 New
9,038 $161,000
Q4 2019

Feb 05, 2020

SELL
$9.73 - $19.31 $77,110 - $153,031
-7,925 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$10.15 - $16.89 $14,281 - $23,764
1,407 Added 21.59%
7,925 $82,000
Q2 2019

Aug 08, 2019

SELL
$14.6 - $20.6 $7,008 - $9,888
-480 Reduced 6.86%
6,518 $102,000
Q1 2019

Apr 26, 2019

BUY
$15.53 - $19.75 $7,035 - $8,946
453 Added 6.92%
6,998 $128,000
Q4 2018

Feb 08, 2019

BUY
$15.58 - $28.41 $27,841 - $50,768
1,787 Added 37.56%
6,545 $109,000
Q3 2018

Nov 13, 2018

BUY
$25.99 - $30.6 $123,660 - $145,594
4,758 New
4,758 $134,000

Others Institutions Holding CLLS

About Cellectis S.A.


  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $71M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.